Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

WisdomTree Europe SmallCap Dividend Fund T.DFE


Primary Symbol: DFE

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree Europe SmallCap Dividend Index. Under normal circumstances, at least 95% of the funds total assets (exclusive of collateral held from securities lending) will be invested in component securities of the index and investments that have economic characteristics that are substantially identical to the economic characteristics of such component securities. The index is a fundamentally weighted index that is comprised of the small-capitalization segment of the European dividend-paying market. The fund is non-diversified.


ARCA:DFE - Post by User

Comment by jayjay3on May 09, 2010 2:59pm
284 Views
Post# 17078929

RE: Lots of promotion ahead

RE: Lots of promotion aheadI think Day4 has huge potential.  My prediction is 50M revenue for Q1 based on their past sales breakdown - modules, systems.  DFE needs to up production and sales or risks insolvency this year.  They are currently contracted to purchase at minimum $137 million in PV cells from their suppliers.  At the current turnover rate, they would be insolvent by the end of the year.  Thankfully, they just upped their production, so there's hope.  The big struggle will be to squeeze a profit since their cell prices were negotiated in 2006/07 during the cell shortages (high prices).
I am hopeful for Q1, but am waiting for Q4 and 2011 overall for this firm.  Still a while, boys, still a while.
<< Previous
Bullboard Posts
Next >>